CurrentEndo
Get Weekly

CurrentEndo coverage · page 13 of 18

Osteoporosis International

Briefs 481–520 of 695 CurrentEndo has covered from this journal, newest publication first

Latest from Osteoporosis International

All coverage, newest first

  1. Osteoporos Int

    Average daily glucocorticoid dose, number of prescription days, and cumulative dose in the initial 90 days of glucocorticoid therapy are associated with subsequent hip and clinical vertebral fracture risk: a retrospective cohort study using a nationwide health insurance claims database in Japan

    Cohort studyBone & mineral

  2. Osteoporos Int

    Comparison of radiological and functional outcomes of conservative treatment with teriparatide and denosumab in thoracolumbar osteoporotic vertebral fracture

    Cohort studyBone & mineral

  3. Osteoporos Int

    A new hip fracture risk index derived from FEA-computed proximal femur fracture loads and energies-to-failure

    Case-control studyBone & mineral

  4. Osteoporos Int

    Selective estrogen receptor modulators (SERMs) with vitamin D composite agent can prevent fracture better than SERMs treatment: based on the National Health Claims Database 2017–2019

    Cohort studyBone & mineral

  5. Osteoporos Int

    Opportunistically identifiable vertebral fractures on routine radiological imaging predict mortality: observational cohort study

    Cohort studyBone & mineral

  6. Osteoporos Int

    A meta-analysis of previous falls and subsequent fracture risk in cohort studies

    Meta-analysisBone & mineral

  7. Osteoporos Int

    A comprehensive meta-analysis of risk factors associated with osteosarcopenic obesity: a closer look at gender, lifestyle and comorbidities

    Meta-analysisBone & mineral

  8. Osteoporos Int

    Association between fatty liver index and controlled attenuation parameters as markers of metabolic dysfunction-associated fatty liver disease and bone mineral density: observational and two-sample Mendelian randomization studies

    Cohort studyBone & mineral

  9. Osteoporos Int

    Trajectories of oral bisphosphonate use after hip fractures: a population-based cohort study

    Cohort studyBone & mineral

  10. Osteoporos Int

    Health-related quality of life in osteoporosis: a systematic review of measurement properties of the QUALEFFO-41

    Meta-analysisBone & mineral

  11. Osteoporos Int

    Utility of MRI-based vertebral bone quality scores and CT-based Hounsfield unit values in vertebral bone mineral density assessment for patients with diffuse idiopathic skeletal hyperostosis

    Diagnostic or prognostic studyBone & mineral

  12. Osteoporos Int

    Effect of recreational cannabis use on bone mineral density: a systematic review

    Meta-analysisBone & mineral

  13. Osteoporos Int

    Higher risk of osteoporosis in adult-onset asthma than childhood-onset asthma: from genetic and prospective evidence

    Cohort studyBone & mineral

  14. Osteoporos Int

    Pre-treatment bone turnover does not influence the level of the response to alendronate in postmenopausal osteoporosis at the bone tissue level

    Secondary analysisBone & mineral

  15. Osteoporos Int

    Changes in spinal sagittal balance after a new osteoporotic vertebral compression fracture

    Cohort studyBone & mineral

  16. Osteoporos Int

    Association between dental diseases and oral hygiene care and the risk of vertebral fracture: a nationwide cohort study

    Cohort studyBone & mineral

  17. Osteoporos Int

    Epidemiology of forearm fractures in women and men in Norway 2008–2019

    Cohort studyBone & mineral

  18. Osteoporos Int

    A prediction model of elderly hip fracture mortality including preoperative red cell distribution width constructed based on the random survival forest (RSF) and Cox risk ratio regression

    Cohort studyBone & mineral

  19. Osteoporos Int

    Geographic variation in bone mineral density and prevalent fractures in the Canadian longitudinal study on aging

    Cross-sectional studyBone & mineral

  20. Osteoporos Int

    Effect of gender on the evolution of pain and quality of life after treatment of symptomatic vertebral fragility fractures

    Secondary analysisBone & mineral

  21. Osteoporos Int

    Systematic review and meta-analysis of preoperative predictors for early mortality following hip fracture surgery

    Meta-analysisBone & mineral

  22. Osteoporos Int

    Hypophosphatasia: presentation and response to asfotase alfa

    Cohort studyBone & mineral

  23. Osteoporos Int

    Proposed diagnostic criteria for the diagnosis of hypophosphatasia in children and adolescents: results from the HPP International Working Group

    Guideline or statementBone & mineral

  24. Osteoporos Int

    The challenge of hypophosphatasia diagnosis in adults: results from the HPP International Working Group Literature Surveillance

    Guideline or statementBone & mineral

  25. Osteoporos Int

    Hypophosphatasia diagnosis: current state of the art and proposed diagnostic criteria for children and adults

    Guideline or statementBone & mineral

  26. Osteoporos Int

    Deprescribing bisphosphonates for older adults with dementia: perspectives of caregivers

    Research articleBone & mineral

  27. Osteoporos Int

    Patients’ preferences for fracture risk communication: the Risk Communication in Osteoporosis (RICO) study

    Cross-sectional studyBone & mineral

  28. Osteoporos Int

    The joint effects of physical activity and sleep duration on risk of osteoporosis in Taiwanese adult population: The Taiwan Biobank Study

    Cross-sectional studyBone & mineral

  29. Osteoporos Int

    Evaluation of costs, osteoporosis treatment, and re-fractures in German collaborative orthogeriatric care after fragility fractures

    Cohort studyBone & mineral

  30. Osteoporos Int

    LMS-based continuous pediatric reference values for soluble receptor activator of nuclear factor kappa B ligand (sRANKL) and osteoprotegerin (OPG) in the HARP cohort

    Research articlePediatric

  31. Osteoporos Int

    Effect of educational intervention on preventing osteoporosis in postmenopausal women

    Mechanistic studyBone & mineral

  32. Osteoporos Int

    The incremental risk of fragility fractures in aging men

    Cohort studyBone & mineral

  33. Osteoporos Int

    Forearm bone mineral density predicts screw loosening after lumbar fusion similar to lumbar Hounsfield unit value in patients with lumbar spondylolisthesis

    Cohort studyBone & mineral

  34. Osteoporos Int

    Vaccination against COVID-19 reduced the mortality risk of COVID-positive hip fracture patients to baseline levels: the nationwide data-linked IMPACT Protect study

    Cohort studyBone & mineral

  35. Osteoporos Int

    Understanding the long-term impact of incident osteoporotic fractures on healthcare utilization and costs in Korean postmenopausal women

    Cohort studyBone & mineral

  36. Osteoporos Int

    Isoflavone intervention and its impact on bone mineral density in postmenopausal women: a systematic review and meta-analysis of randomized controlled trials

    Meta-analysisBone & mineral

  37. Osteoporos Int

    Performance of FRAX in older adults with frailty: the Framingham Heart Study

    Cohort studyBone & mineral

  38. Osteoporos Int

    Radiomorphometric indices of the mandible as indicators of decreased bone mineral density and osteoporosis – meta-analysis and systematic review

    Meta-analysisBone & mineral

  39. Osteoporos Int

    Growth hormone and testosterone delay vertebral fractures in boys with muscular dystrophy on chronic glucocorticoids

    Cohort studyPediatric

  40. Osteoporos Int

    Risk of wrist fracture, estimated by the load-to-strength ratio, declines following sleeve gastrectomy in adolescents and young adults

    Cohort studyObesity

All 695 Briefs in ExploreShowing Briefs 481–520 of 695, newest first